Next Post

Morgan Stanley lists biotechs with negative enterprise value, 2022 catalysts (NASDAQ:GLPG)

[ad_1] ipopba/iStock via Getty Pictures Reviewing its protection on biotechs with adverse organization values, Morgan Stanley says that the selection of businesses on the record with prospective catalysts in 2022 has greater to 27 in May well from 20 formerly. Including current market capitalization to overall personal debt and deducting […]